Professionals 126 results
Capabilities 37 results
Industry
Industry
Industry
Experience 27 results
Experience
|March 15, 2024
US$900M Constellation Energy Generation, LLC Public Offering of Green Senior Notes
Experience
|February 15, 2024
Winston represented Eurofeu's partners in the context of IK Partners' majority stake acquisition
Insights & News 704 results
Client Alert
|July 1, 2024
|8 Min Read
The Supreme Court announced a major restriction on a common practice for Chapter 11 bankruptcy reorganization plans, sending a multi-billion-dollar settlement involving the Purdue Pharma opioid litigation back to the drawing board. In Harrington v. Purdue Pharma L.P., the high court held that the bankruptcy court could not enter a release benefitting the Sackler family, who were accused of funneling $11 billion from the now-bankrupt Purdue Pharma but had not themselves filed bankruptcy petitions. The plan would have released the Sacklers in exchange for contributing up to $6 billion to pay opioid-related claims against them and Purdue Pharma in connection with OxyContin addiction.
Recognitions
|June 28, 2024
|1 Min Read
Winston Attorneys Featured on 2024 Lawdragon 500 X – The Next Generation List
Client Alert
|June 26, 2024
|10+ Min Read
Harnessing Generative AI: Best Practices for Trade Secret Protection
Generative AI tools present several unique trade secret protection issues. Company trade secrets may come in at the machine learning stage as a data set used for training, or in the input stage if an employee user feeds the tool proprietary information to produce an output. As a Generative AI tool may store information after its immediate use, using such tools may risk exposure of trade secrets used at inputs by users, if not properly licensed and trained. Moreover, both inputs and outputs, as well as the tool itself, may be cause for trade secret protection.
Other Results 26 results
Site Content
Law Glossary
Location